Aescap Venture
Europe, Noord-Holland, The Netherlands, Amsterdam
Description
Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.
Investor Profile
Aescap Venture has made 28 investments, with 0 in the past 12 months and 32% as lead.
Stage Focus
- Series A (32%)
- Series Unknown (25%)
- Series B (18%)
- Series C (11%)
- Post Ipo Equity (4%)
- Series D (4%)
- Series G (4%)
- Private Equity (4%)
Country Focus
- The Netherlands (25%)
- United Kingdom (25%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Denmark (14%)
- Switzerland (11%)
- Germany (7%)
- Austria (7%)
- Belgium (7%)
- Italy (4%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Biopharma
- Health Diagnostics
- Health Care
- Oncology
- Chemical
- Therapeutics
- Genetics
- Renewable Energy
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
